Assenagon Asset Management
BIO icon

Assenagon Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$497K Sell
2,059
-2,366
-53% -$571K ﹤0.01% 1008
2025
Q1
$1.08M Buy
+4,425
New +$1.08M ﹤0.01% 863
2024
Q4
Sell
-41,960
Closed -$14M 1313
2024
Q3
$14M Sell
41,960
-12,372
-23% -$4.14M 0.03% 417
2024
Q2
$14.8M Buy
54,332
+14,457
+36% +$3.95M 0.03% 327
2024
Q1
$13.8M Buy
39,875
+27,270
+216% +$9.43M 0.03% 331
2023
Q4
$4.07M Buy
12,605
+6,429
+104% +$2.08M 0.01% 667
2023
Q3
$2.21M Buy
6,176
+4,306
+230% +$1.54M 0.01% 794
2023
Q2
$709K Sell
1,870
-177
-9% -$67.1K ﹤0.01% 1014
2023
Q1
$981K Sell
2,047
-98,544
-98% -$47.2M ﹤0.01% 1022
2022
Q4
$42.3M Buy
100,591
+88,853
+757% +$37.4M 0.15% 118
2022
Q3
$4.9M Hold
11,738
0.02% 472
2022
Q2
$5.81M Sell
11,738
-10,021
-46% -$4.96M 0.02% 477
2022
Q1
$12.3M Buy
21,759
+7,791
+56% +$4.39M 0.03% 293
2021
Q4
$10.6M Sell
13,968
-3,431
-20% -$2.59M 0.03% 293
2021
Q3
$13M Buy
17,399
+16,302
+1,486% +$12.2M 0.04% 225
2021
Q2
$707K Sell
1,097
-28,273
-96% -$18.2M ﹤0.01% 935
2021
Q1
$16.8M Sell
29,370
-69,186
-70% -$39.5M 0.07% 216
2020
Q4
$57.5M Buy
98,556
+95,813
+3,493% +$55.9M 0.25% 58
2020
Q3
$1.41M Sell
2,743
-151,825
-98% -$78.3M 0.01% 642
2020
Q2
$69.8M Buy
154,568
+87,733
+131% +$39.6M 0.45% 29
2020
Q1
$23.4M Buy
+66,835
New +$23.4M 0.19% 76
2019
Q3
Sell
-91,268
Closed -$28.5M 817
2019
Q2
$28.5M Buy
91,268
+25,065
+38% +$7.83M 0.21% 65
2019
Q1
$20.2M Buy
66,203
+43,964
+198% +$13.4M 0.19% 85
2018
Q4
$5.16M Sell
22,239
-96,258
-81% -$22.4M 0.06% 189
2018
Q3
$37.1M Sell
118,497
-7,498
-6% -$2.35M 0.37% 37
2018
Q2
$36.4M Sell
125,995
-2,971
-2% -$857K 0.42% 40
2018
Q1
$32.3M Buy
128,966
+120,999
+1,519% +$30.3M 0.42% 38
2017
Q4
$1.9M Buy
+7,967
New +$1.9M 0.02% 385
2017
Q3
Sell
-66,086
Closed -$15M 393
2017
Q2
$15M Buy
+66,086
New +$15M 0.32% 11
2017
Q1
Sell
-100,700
Closed -$18.4M 192
2016
Q4
$18.4M Buy
+100,700
New +$18.4M 0.34% 30